| 【Company Research】Property - Weekly highlight: Awaiting more positive signs on property sales |
| 【Company Research】CSPC Pharmaceutical (1093 HK) - Accelerating growth in finished drug sales |
| 【行业研究】医药 - 海外CXO/生命科学上游1Q24业绩剖析：订单走弱，但24下半年需求复苏仍是共识 |
| 【Company Research】Atour Lifestyle (ATAT US) - Guidance raised, backed by robust retail sales |
| 【行业研究】中国医药 - 重视设备更新的政策机遇 |
| 【Company Research】Weibo (WB US) - Ad revenue growth recovery still takes time |
| 【Company Research】Topsports (6110 HK) - This is likely a rocky-road turnaround |
| 【Company Research】Ke Holdings (BEKE US) - Eyeing on the pace of fundamental recovery post sentiment rebound |
| 【Company Research】Bilibili (BILI US) - Revitalizing business model; intact breakeven target |
| 【Company Research】NetEase (NTES US) - Inline 1Q24 results; upbeat on game revenue growth reacceleration in 2H24E |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
